FDA Finalizes Its Informed Consent Guidance for IRBs, Clinical Investigators and Sponsors
Hall Render
OCTOBER 5, 2023
Food and Drug Administration (“FDA”) finalized “ Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors ” (“Final Guidance”), following the FDA’s earlier issuance of draft guidance on the subject in July 2014.
40 
Let's personalize your content